Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Sorrento Therapeutics (SRNE)

Sorrento Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SRNE
DateTimeSourceHeadlineSymbolCompany
03/11/202321:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRNESorrento Therapeutics Inc
27/10/202321:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRNESorrento Therapeutics Inc
13/09/202302:51Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRNESorrento Therapeutics Inc
28/08/202322:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRNESorrento Therapeutics Inc
07/08/202321:15Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:SRNESorrento Therapeutics Inc
01/08/202311:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRNESorrento Therapeutics Inc
13/07/202311:26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRNESorrento Therapeutics Inc
21/06/202322:25Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:SRNESorrento Therapeutics Inc
20/06/202322:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRNESorrento Therapeutics Inc
15/06/202314:44Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRNESorrento Therapeutics Inc
05/06/202314:00GlobeNewswire Inc.Shanghai Escugen Biotechnology Co., Ltd., a partner of Levena Biopharma, a Sorrento Company, releases positive results from a first-in-human study of ESG401, a TROP2 Antibody Drug Conjugate in patients with locally advanced/metastatic solid tumors at the ANASDAQ:SRNESorrento Therapeutics Inc
19/05/202311:04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRNESorrento Therapeutics Inc
15/05/202320:18Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SRNESorrento Therapeutics Inc
15/05/202317:04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRNESorrento Therapeutics Inc
12/05/202322:29Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:SRNESorrento Therapeutics Inc
09/05/202311:03Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:SRNESorrento Therapeutics Inc
03/05/202311:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRNESorrento Therapeutics Inc
20/04/202322:28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRNESorrento Therapeutics Inc
20/04/202317:09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRNESorrento Therapeutics Inc
12/04/202313:51Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:SRNESorrento Therapeutics Inc
10/04/202322:23Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:SRNESorrento Therapeutics Inc
10/04/202320:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRNESorrento Therapeutics Inc
31/03/202311:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRNESorrento Therapeutics Inc
20/03/202323:54Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SRNESorrento Therapeutics Inc
20/03/202310:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRNESorrento Therapeutics Inc
10/03/202316:22Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SRNESorrento Therapeutics Inc
08/03/202319:20Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SRNESorrento Therapeutics Inc
22/02/202314:25AllPennyStocks.comBankruptcy Court Approval Causes Premarket Buying PressureNASDAQ:SRNESorrento Therapeutics Inc
21/02/202322:57PR Newswire (US)Sorrento Therapeutics, Inc. Receives Court Approval for $75 Million Financing in Chapter 11 CaseNASDAQ:SRNESorrento Therapeutics Inc
21/02/202321:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRNESorrento Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:SRNE